Skip to main content
Top
Published in: Current Hypertension Reports 6/2014

01-06-2014 | Hypertensive Emergencies (BM Baumann, Section Editor)

Control of Blood Pressure in Hypertensive Neurological Emergencies

Authors: Lisa Manning, Thompson G. Robinson, Craig S. Anderson

Published in: Current Hypertension Reports | Issue 6/2014

Login to get access

Abstract

Neurological hypertensive emergencies cause significant morbidity and mortality. Most occur in the setting of ischaemic stroke, spontaneous intracerebral hemorrhage (ICH), or subarachnoid hemorrhage (SAH), but other causes relate to hypertensive encephalopathy and reversible cerebral vasoconstriction syndrome (RCVS). Prompt and controlled reduction of blood pressure (BP) is necessary, although there remains uncertainty as to the optimal rate of decline and ideal antihypertensive agent. There is probably no single treatment strategy that covers all neurological hypertensive emergencies. Prompt diagnosis of the underlying disorder, recognition of its severity, and appropriate targeted treatment are required. Lack of comparative-effectiveness data leaves clinicians with limited evidence-based guidance in management, although significant developments have occurred recently in the field. In this article, we review the management of specific neurological hypertensive emergencies, with particular emphasis on recent evidence.
Literature
1.
go back to reference Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.PubMed Chobanian AV, Bakris GL, Black HR, et al. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;42(6):1206–52.PubMed
2.•
go back to reference Peacock IV WF, Hilleman DE, Levy PD, Rhoney DH, Varon J. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am J Emerg Med. 2012;30(6):981–93. A recent systematic review of treatment in hypertensive crises. The results of this review show comparable efficacy and safety for nicardipine and labetalol, although nicardipine appears to provide more predictable and consistent BP control than labetalol. In a number of included studies there was a theme of a relative lack of awareness among health care professionals regarding the use of nicardipine in patients with stroke, despite its inclusion in AHA/ASA guidelines, and authors suggest a requirement for education regarding the appropriate use and the approved indications of the drug. PubMed Peacock IV WF, Hilleman DE, Levy PD, Rhoney DH, Varon J. A systematic review of nicardipine vs labetalol for the management of hypertensive crises. Am J Emerg Med. 2012;30(6):981–93. A recent systematic review of treatment in hypertensive crises. The results of this review show comparable efficacy and safety for nicardipine and labetalol, although nicardipine appears to provide more predictable and consistent BP control than labetalol. In a number of included studies there was a theme of a relative lack of awareness among health care professionals regarding the use of nicardipine in patients with stroke, despite its inclusion in AHA/ASA guidelines, and authors suggest a requirement for education regarding the appropriate use and the approved indications of the drug. PubMed
3.
go back to reference Papadopoulus D, Lordanis M, Thomopoulos C, Makris T, et al. Hypertension crisis. Blood Press. 2010;19:328–36. Papadopoulus D, Lordanis M, Thomopoulos C, Makris T, et al. Hypertension crisis. Blood Press. 2010;19:328–36.
4.
go back to reference Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension. 1996;27(1):144–7.PubMed Zampaglione B, Pascale C, Marchisio M, Cavallo-Perin P. Hypertensive urgencies and emergencies: prevalence and clinical presentation. Hypertension. 1996;27(1):144–7.PubMed
5.
go back to reference Martin JFV, Higashiama E, Garcia E, et al. Hypertensive crisis profile. Prevelence and clinical presentation. Arq Bras Cardiol. 2004;83:131–6.PubMed Martin JFV, Higashiama E, Garcia E, et al. Hypertensive crisis profile. Prevelence and clinical presentation. Arq Bras Cardiol. 2004;83:131–6.PubMed
6.
go back to reference Bennett NM, Shea S. Hypertensive emergency: case criteria, sociodemographic profile and previous care of 100 cases. Am J Public Health. 1988;78:636–40.PubMedPubMedCentral Bennett NM, Shea S. Hypertensive emergency: case criteria, sociodemographic profile and previous care of 100 cases. Am J Public Health. 1988;78:636–40.PubMedPubMedCentral
7.
go back to reference Varon J. Treatment of acute hypertension: current and newer agents. Drugs. 2008;68:283–97.PubMed Varon J. Treatment of acute hypertension: current and newer agents. Drugs. 2008;68:283–97.PubMed
8.
go back to reference Mancia G, Fagard R, Narkiewicz K, et al. 2013 practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC task force for the management of arterial hypertension. J Hypertens. 2013;31(10):1925–38. Mancia G, Fagard R, Narkiewicz K, et al. 2013 practice guidelines for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC): ESH/ESC task force for the management of arterial hypertension. J Hypertens. 2013;31(10):1925–38.
9.
go back to reference Paulson OB, Strandgaard S, Edvinson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990;2:161–92.PubMed Paulson OB, Strandgaard S, Edvinson L. Cerebral autoregulation. Cerebrovasc Brain Metab Rev. 1990;2:161–92.PubMed
10.
go back to reference Symon L, Held K, Dorsch NWC. A study of regional autoregulation in the cerebral circulation to increased perfusion pressure in normocapnia and hypercapnia. Stroke. 1973;4(2):139–47.PubMed Symon L, Held K, Dorsch NWC. A study of regional autoregulation in the cerebral circulation to increased perfusion pressure in normocapnia and hypercapnia. Stroke. 1973;4(2):139–47.PubMed
11.
go back to reference Rose JC, Mayer SA. Optimizing blood pressure in neurologic emergencies. Neurocrit Care. 2004;1:287–99.PubMed Rose JC, Mayer SA. Optimizing blood pressure in neurologic emergencies. Neurocrit Care. 2004;1:287–99.PubMed
12.
go back to reference Dawson SL, Panerai R, Potter J. Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke. Cerebrovasc Dis. 2003;16:69–75.PubMed Dawson SL, Panerai R, Potter J. Serial changes in static and dynamic cerebral autoregulation after acute ischaemic stroke. Cerebrovasc Dis. 2003;16:69–75.PubMed
13.
go back to reference Aries MJH, Elting JW, De Keyser J, Kremer BPH, Vroomen PCAJ. Cerebral autoregulation in stroke: a review of transcranial doppler studies. Stroke. 2010;41(11):2697–704.PubMed Aries MJH, Elting JW, De Keyser J, Kremer BPH, Vroomen PCAJ. Cerebral autoregulation in stroke: a review of transcranial doppler studies. Stroke. 2010;41(11):2697–704.PubMed
14.
go back to reference Yamamoto S, Nishizawa S, Tsukada H, et al. Cerebral blood flow autoregulation following subarachnoid hemorrhage in rats: chronic vasospasm shifts the upper and lower limits of the autoregulatory range toward higher blood pressures. Brain Res. 1998;782(1–2):194–201.PubMed Yamamoto S, Nishizawa S, Tsukada H, et al. Cerebral blood flow autoregulation following subarachnoid hemorrhage in rats: chronic vasospasm shifts the upper and lower limits of the autoregulatory range toward higher blood pressures. Brain Res. 1998;782(1–2):194–201.PubMed
15.
go back to reference Strangaard S, Paulson OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens. 1989;6:486–92. Strangaard S, Paulson OB. Cerebral blood flow and its pathophysiology in hypertension. Am J Hypertens. 1989;6:486–92.
16.
go back to reference Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118(2):176–87.PubMed Qureshi AI. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation. 2008;118(2):176–87.PubMed
17.
go back to reference Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29.PubMedPubMedCentral Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41(9):2108–29.PubMedPubMedCentral
18.
go back to reference The Brain Trauma Foundation. Guidelines for cerebral perfusion pressure. J Neurotrauma. 2000;17:507–11. The Brain Trauma Foundation. Guidelines for cerebral perfusion pressure. J Neurotrauma. 2000;17:507–11.
19.
go back to reference Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of diseases study 2010. Lancet. 2012;380(9859):2095–128.PubMed Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of diseases study 2010. Lancet. 2012;380(9859):2095–128.PubMed
20.
go back to reference International Stroke Trial Collaborative Group. The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569–81. International Stroke Trial Collaborative Group. The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet. 1997;349(9065):1569–81.
21.
go back to reference Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Hussein HM. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32–8.PubMedPubMedCentral Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Hussein HM. Prevalence of elevated blood pressure in 563,704 adult patients with stroke presenting to the ED in the United States. Am J Emerg Med. 2007;25:32–8.PubMedPubMedCentral
22.
go back to reference Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis. Retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register (SITS-ISTR). Stroke. 2009;40:2442–9.PubMed Ahmed N, Wahlgren N, Brainin M, Castillo J, Ford GA, Kaste M, et al. Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke treated with intravenous thrombolysis. Retrospective analysis from safe implementation of thrombolysis in stroke-international stroke thrombolysis register (SITS-ISTR). Stroke. 2009;40:2442–9.PubMed
23.
go back to reference Robinson T. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovasc Dis. 1997;7:264–72. Robinson T. The predictive role of 24-hour compared to casual blood pressure levels on outcome following acute stroke. Cerebrovasc Dis. 1997;7:264–72.
24.
go back to reference Dawson SL, Manktelow BN, Robinson TG, Panerai RB, Potter JF. Which parameters of beat-to-beat blood pressure and variability best predict early outcome after acute ischemic stroke? Stroke. 2000;31(2):463–8.PubMed Dawson SL, Manktelow BN, Robinson TG, Panerai RB, Potter JF. Which parameters of beat-to-beat blood pressure and variability best predict early outcome after acute ischemic stroke? Stroke. 2000;31(2):463–8.PubMed
25.
go back to reference Ahmed N, Wahlgren N. High initial blood pressure after acute stroke is associated with poor functional outcome. J Intern Med. 2001;249:467–73.PubMed Ahmed N, Wahlgren N. High initial blood pressure after acute stroke is associated with poor functional outcome. J Intern Med. 2001;249:467–73.PubMed
26.
go back to reference Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG, for the IST Collaborative Group. Blood pressure and clinical outcomes in the international stroke trial. Stroke. 2002;33(5):1315–20.PubMed Leonardi-Bee J, Bath PMW, Phillips SJ, Sandercock PAG, for the IST Collaborative Group. Blood pressure and clinical outcomes in the international stroke trial. Stroke. 2002;33(5):1315–20.PubMed
27.
go back to reference Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR. GAIN international steering committee and investigators. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN international trial. Stroke. 2003;34:2420–5.PubMed Aslanyan S, Fazekas F, Weir CJ, Horner S, Lees KR. GAIN international steering committee and investigators. Effect of blood pressure during the acute period of ischemic stroke on stroke outcome: a tertiary analysis of the GAIN international trial. Stroke. 2003;34:2420–5.PubMed
28.
go back to reference Aslanyan S, Weir CJ, Lees KR, GAIN International Steering Committee and Investigators. Elevated pulse pressure during the acute period of ischemic stroke is associated with poor stroke outcome. Stroke. 2004;33:153–5. Aslanyan S, Weir CJ, Lees KR, GAIN International Steering Committee and Investigators. Elevated pulse pressure during the acute period of ischemic stroke is associated with poor stroke outcome. Stroke. 2004;33:153–5.
29.
go back to reference Jensen MB, Yoo B, Clarke WR, Davis PH, Adams Jr HR. Blood pressure as an independent prognostic factor in acute ischemic stroke. Can J Neurol Sci. 2006;33:34–8.PubMed Jensen MB, Yoo B, Clarke WR, Davis PH, Adams Jr HR. Blood pressure as an independent prognostic factor in acute ischemic stroke. Can J Neurol Sci. 2006;33:34–8.PubMed
30.
go back to reference Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens. 2005;23:1217–23.PubMed Okumura K, Ohya Y, Maehara A, Wakugami K, Iseki K, Takishita S. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens. 2005;23:1217–23.PubMed
31.•
go back to reference Sandset EC, Bath PM, Boysen G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377(9767):741–50. 2029 patients with acute stroke and SBP > 140mmHg were allocated to candesartan or placebo. In contrast to other recent trials (CHIPPS), there was no indication that careful blood-pressure lowering treatment with the angiotensin-receptor blocker candesartan is beneficial in patients with acute stroke and raised blood pressure. If anything, the evidence suggested a harmful effect. PubMed Sandset EC, Bath PM, Boysen G, et al. The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial. Lancet. 2011;377(9767):741–50. 2029 patients with acute stroke and SBP > 140mmHg were allocated to candesartan or placebo. In contrast to other recent trials (CHIPPS), there was no indication that careful blood-pressure lowering treatment with the angiotensin-receptor blocker candesartan is beneficial in patients with acute stroke and raised blood pressure. If anything, the evidence suggested a harmful effect. PubMed
32.
go back to reference Robinson TG, Potter JF, Ford GA, et al. Effects of antihypertensive treatment after acute stroke in the continue or stop post-stroke antihypertensives collaborative study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 2010;9(8):767–75.PubMed Robinson TG, Potter JF, Ford GA, et al. Effects of antihypertensive treatment after acute stroke in the continue or stop post-stroke antihypertensives collaborative study (COSSACS): a prospective, randomised, open, blinded-endpoint trial. Lancet Neurol. 2010;9(8):767–75.PubMed
33.
go back to reference Potter JF, Robinson TG, Ford GA, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8(1):48–56.PubMed Potter JF, Robinson TG, Ford GA, et al. Controlling hypertension and hypotension immediately post-stroke (CHHIPS): a randomised, placebo-controlled, double-blind pilot trial. Lancet Neurol. 2009;8(1):48–56.PubMed
34.
go back to reference Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for treatment of acute lacunar stroke syndromes. Lancet. 2004;363:439–45. Intravenous Magnesium Efficacy in Stroke (IMAGES) Study Investigators. Magnesium for treatment of acute lacunar stroke syndromes. Lancet. 2004;363:439–45.
35.
go back to reference Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T. Intravenous Nimodipine west European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis. 1994;4:204–10. Wahlgren NG, MacMahon DG, De Keyser J, Indredavik B, Ryman T. Intravenous Nimodipine west European Stroke Trial (INWEST) of nimodipine in the treatment of acute ischaemic stroke. Cerebrovasc Dis. 1994;4:204–10.
36.
go back to reference Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J. 1988;296:737–41. Barer DH, Cruickshank JM, Ebrahim SB, Mitchell JR. Low dose beta blockade in acute stroke ("BEST" trial): an evaluation. Br Med J. 1988;296:737–41.
37.•
go back to reference He J, Zhang Y, Xu T, et al, for the CATIS investigators. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischaemic stroke. JAMA. 2014;311(5):479–489. doi:https://doi.org/10.1001/jama.2013.282543. The most recently published large trial of blood pressure reduction in ischemic stroke, in which 4071 patients with acute stroke and elevated SBP were randomized to antihypertensive treatment (with the aim of lowering SBP by 10 to 25% in 24 hours), or to discontinue all antihypertensive medications. BP reduction did not reduce the likelihood of death or major disability at 14 days. PubMed He J, Zhang Y, Xu T, et al, for the CATIS investigators. Effects of immediate blood pressure reduction on death and major disability in patients with acute ischaemic stroke. JAMA. 2014;311(5):479–489. doi:https://​doi.​org/​10.​1001/​jama.​2013.​282543. The most recently published large trial of blood pressure reduction in ischemic stroke, in which 4071 patients with acute stroke and elevated SBP were randomized to antihypertensive treatment (with the aim of lowering SBP by 10 to 25% in 24 hours), or to discontinue all antihypertensive medications. BP reduction did not reduce the likelihood of death or major disability at 14 days. PubMed
38.
go back to reference Schrader J, Lüders S, Kulschewski A, et al. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke. 2003;34(7):1699–703.PubMed Schrader J, Lüders S, Kulschewski A, et al. The ACCESS study: evaluation of acute candesartan cilexetil therapy in stroke survivors. Stroke. 2003;34(7):1699–703.PubMed
39.
go back to reference Bath PMW, Martin RH, Palesch Y, et al. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke. 2009;40(11):3541–6.PubMed Bath PMW, Martin RH, Palesch Y, et al. Effect of telmisartan on functional outcome, recurrence, and blood pressure in patients with acute mild ischemic stroke: a PRoFESS subgroup analysis. Stroke. 2009;40(11):3541–6.PubMed
40.
go back to reference Astrid G, Hornslien M, on Behalf of the Scandinavian Candesartan Acute Stroke Trial Study Group, et al. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the scandinavian candesartan acute stroke trial. Stroke. 2013;44:2022–4. Astrid G, Hornslien M, on Behalf of the Scandinavian Candesartan Acute Stroke Trial Study Group, et al. Effects of candesartan in acute stroke on cognitive function and quality of life: results from the scandinavian candesartan acute stroke trial. Stroke. 2013;44:2022–4.
43.
go back to reference Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35(3):776–85.PubMed Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004;35(3):776–85.PubMed
45.
go back to reference Bath P. International society of hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens. 2003;21:665–72.PubMed Bath P. International society of hypertension (ISH): statement on the management of blood pressure in acute stroke. J Hypertens. 2003;21:665–72.PubMed
46.
go back to reference Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American academy of neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115(20):e478–534.PubMed Adams HP, del Zoppo G, Alberts MJ, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American academy of neurology affirms the value of this guideline as an educational tool for neurologists. Circulation. 2007;115(20):e478–534.PubMed
47.
go back to reference Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.PubMed Jauch EC, Saver JL, Adams HP, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2013;44:870–947.PubMed
49.
go back to reference Saposnik G, Del Brutto OH, for the Iberoamerican Society of Cerebrovascular Diseases. Stroke in south America: a systematic review of incidence, prevalence, and stroke subtypes. Stroke. 2003;34(9):2103–7.PubMed Saposnik G, Del Brutto OH, for the Iberoamerican Society of Cerebrovascular Diseases. Stroke in south America: a systematic review of incidence, prevalence, and stroke subtypes. Stroke. 2003;34(9):2103–7.PubMed
50.
go back to reference Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1):43–53.PubMed Feigin VL, Lawes CM, Bennett DA, Anderson CS. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol. 2003;2(1):43–53.PubMed
51.
go back to reference Zhang Y, Reilly K, Tong W, et al. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens. 2008;26:1446–52.PubMed Zhang Y, Reilly K, Tong W, et al. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens. 2008;26:1446–52.PubMed
52.
go back to reference Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35(6):1364–7.PubMed Ohwaki K, Yano E, Nagashima H, Hirata M, Nakagomi T, Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke. 2004;35(6):1364–7.PubMed
53.
go back to reference Robinson TG, Potter JF. Blood pressure in acute stroke. Age Ageing. 2004;33(1):6–12.PubMed Robinson TG, Potter JF. Blood pressure in acute stroke. Age Ageing. 2004;33(1):6–12.PubMed
54.
go back to reference Rodriguez-Luna D, Piñeiro S, Rubiera M, et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol. 2013;20(9):1277–83.PubMed Rodriguez-Luna D, Piñeiro S, Rubiera M, et al. Impact of blood pressure changes and course on hematoma growth in acute intracerebral hemorrhage. Eur J Neurol. 2013;20(9):1277–83.PubMed
55.
go back to reference Jauch EC, Lindsell CJ, Adeoye O, Khoury J, Barsan W, Broderick J. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061.PubMed Jauch EC, Lindsell CJ, Adeoye O, Khoury J, Barsan W, Broderick J. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke. 2006;37:2061.PubMed
56.
go back to reference Butcher KS, Jeerakathil T, Hill M, et al. The intracerebral haemorrhage acutely decreasing arterial pressure trial. Stroke. 2013;44:620–626.PubMed Butcher KS, Jeerakathil T, Hill M, et al. The intracerebral haemorrhage acutely decreasing arterial pressure trial. Stroke. 2013;44:620–626.PubMed
57.
go back to reference Willmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43(1):18–24.PubMed Willmot M, Leonardi-Bee J, Bath PMW. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004;43(1):18–24.PubMed
58.
go back to reference Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med. 2004;255:257–65.PubMed Vemmos KN, Tsivgoulis G, Spengos K, Zakopoulos N, Synetos A. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med. 2004;255:257–65.PubMed
59.
go back to reference Intercollegiate Stroke Working Party. National clinical guideline for stroke. 4th ed. London: Royal College of Physicians; 2012. Intercollegiate Stroke Working Party. National clinical guideline for stroke. 4th ed. London: Royal College of Physicians; 2012.
60.••
go back to reference Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65. This large trial of intensive BP lowering versus standard guideline care in patients with acute ICH and elevated SBP, showed borderline significant reduction in poor outcome at 90-days, defined by death or major disability, with a significant favorable shift in an ordinal analysis of the distribution of scores on the modified Rankin Scale in the intensive treatment group. Furthermore, intensive BP reduction was shown to be safe and to result in significantly better health-related quality of life. Effects were consistant across different patient and disease characteristics. PubMed Anderson CS, Heeley E, Huang Y, et al. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage. N Engl J Med. 2013;368(25):2355–65. This large trial of intensive BP lowering versus standard guideline care in patients with acute ICH and elevated SBP, showed borderline significant reduction in poor outcome at 90-days, defined by death or major disability, with a significant favorable shift in an ordinal analysis of the distribution of scores on the modified Rankin Scale in the intensive treatment group. Furthermore, intensive BP reduction was shown to be safe and to result in significantly better health-related quality of life. Effects were consistant across different patient and disease characteristics. PubMed
61.
go back to reference Qureshi A. Antihypertensive treatment of acute cerebral hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007;6:56–66.PubMed Qureshi A. Antihypertensive treatment of acute cerebral hemorrhage (ATACH): rationale and design. Neurocrit Care. 2007;6:56–66.PubMed
62.
go back to reference Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57:18–24.PubMed Powers WJ, Zazulia AR, Videen TO, Adams RE, Yundt KD, Aiyagari V. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology. 2001;57:18–24.PubMed
63.
go back to reference Qureshi AI, Mohammad YM, Yahia AM, Suarez JI, Siddiqui AM. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med. 2005;20:44–52. Qureshi AI, Mohammad YM, Yahia AM, Suarez JI, Siddiqui AM. A prospective multicenter study to evaluate the feasibility and safety of aggressive antihypertensive treatment in patients with acute intracerebral hemorrhage. J Intensive Care Med. 2005;20:44–52.
64.
go back to reference Qureshi AI, Bliwise DL, Bliwise NG, Akbar MS, Uzen G, Frankel MR. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med. 1999;27:480–5.PubMed Qureshi AI, Bliwise DL, Bliwise NG, Akbar MS, Uzen G, Frankel MR. Rate of 24-hour blood pressure decline and mortality after spontaneous intracerebral hemorrhage: a retrospective analysis with a random effects regression model. Crit Care Med. 1999;27:480–5.PubMed
65.
go back to reference Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7(5):391–9.PubMed Anderson CS, Huang Y, Wang JG, et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol. 2008;7(5):391–9.PubMed
66.
go back to reference Vaughan C, Delanty N. Hypertensive emergencies. Lancet. 2000;356:411–7.PubMed Vaughan C, Delanty N. Hypertensive emergencies. Lancet. 2000;356:411–7.PubMed
67.
go back to reference Hinchey J, Chaves C, Appignani B. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1999;52:1497–500. Hinchey J, Chaves C, Appignani B. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1999;52:1497–500.
68.
go back to reference Pearce C, Wallin J. Labetalol and other agents that block both alpha and beta adrenergic receptors. Cleve Clin J Med. 1994;61:59–69.PubMed Pearce C, Wallin J. Labetalol and other agents that block both alpha and beta adrenergic receptors. Cleve Clin J Med. 1994;61:59–69.PubMed
69.
go back to reference Rose J, Mayer S. Optimising blood pressure in neurological emergencies. Neurocrit Care. 2004;1:287–99.PubMed Rose J, Mayer S. Optimising blood pressure in neurological emergencies. Neurocrit Care. 2004;1:287–99.PubMed
70.
go back to reference Neutel J, Smith D, Wallin D, et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens. 1994;7:623–8.PubMed Neutel J, Smith D, Wallin D, et al. A comparison of intravenous nicardipine and sodium nitroprusside in the immediate treatment of severe hypertension. Am J Hypertens. 1994;7:623–8.PubMed
71.
go back to reference Steiner T et al. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35:93–112.PubMed Steiner T et al. European stroke organization guidelines for the management of intracranial aneurysms and subarachnoid haemorrhage. Cerebrovasc Dis. 2013;35:93–112.PubMed
72.
go back to reference King Jr JT. Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin N Am. 1997;7:659–68.PubMed King Jr JT. Epidemiology of aneurysmal subarachnoid hemorrhage. Neuroimaging Clin N Am. 1997;7:659–68.PubMed
73.
go back to reference Hop J, Rinkel GJ, et al. Case fatality rates and functional outcome after sud-arachnoid haemorrhage: a systematic review. Stroke. 1997;28:660–4.PubMed Hop J, Rinkel GJ, et al. Case fatality rates and functional outcome after sud-arachnoid haemorrhage: a systematic review. Stroke. 1997;28:660–4.PubMed
74.
go back to reference Qureshi AI, Suri MF, Yahia AM, Suarez JI, Guterman LR, Hopkins LN. Risk factors for subarachnoid hemorrhage. Neurosurgery. 2001;49:607–12.PubMed Qureshi AI, Suri MF, Yahia AM, Suarez JI, Guterman LR, Hopkins LN. Risk factors for subarachnoid hemorrhage. Neurosurgery. 2001;49:607–12.PubMed
75.
go back to reference Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38(8):2315–21.PubMed Rosengart AJ, Schultheiss KE, Tolentino J, Macdonald RL. Prognostic factors for outcome in patients with aneurysmal subarachnoid hemorrhage. Stroke. 2007;38(8):2315–21.PubMed
76.
go back to reference Gomis P, Rousseaux P, Johy D, et al. Initial prognostic factors of aneurysmal subarachnoid haemorrhage. Neurochirurgie. 1994;40:18–30.PubMed Gomis P, Rousseaux P, Johy D, et al. Initial prognostic factors of aneurysmal subarachnoid haemorrhage. Neurochirurgie. 1994;40:18–30.PubMed
77.
go back to reference Duran L, Balci K, et al. Has admission blood pressure any prognostic value in patients with subarachnoid haemorrhage: an emergency department experience. J Clin Hypertens. 2013;15:737–41. Duran L, Balci K, et al. Has admission blood pressure any prognostic value in patients with subarachnoid haemorrhage: an emergency department experience. J Clin Hypertens. 2013;15:737–41.
79.
go back to reference Wijdicks EFM, Vermeulen M, Murray GD, Hijdra A, van Gijn J. The effects of treating hypertension following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 1990;92(2):111–7.PubMed Wijdicks EFM, Vermeulen M, Murray GD, Hijdra A, van Gijn J. The effects of treating hypertension following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 1990;92(2):111–7.PubMed
80.
go back to reference Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke. 2001;32(5):1176–80.PubMed Ohkuma H, Tsurutani H, Suzuki S. Incidence and significance of early aneurysmal rebleeding before neurosurgical or neurological management. Stroke. 2001;32(5):1176–80.PubMed
81.
go back to reference Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62(3):410–6.PubMed Naidech AM, Janjua N, Kreiter KT, et al. Predictors and impact of aneurysm rebleeding after subarachnoid hemorrhage. Arch Neurol. 2005;62(3):410–6.PubMed
82.
go back to reference Fujii Y et al. Ultra early rebleeding in sub arachnoid haemorrhage. J Neurosurg. 1996;84:35–42.PubMed Fujii Y et al. Ultra early rebleeding in sub arachnoid haemorrhage. J Neurosurg. 1996;84:35–42.PubMed
83.
go back to reference Budohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Steiner LA, Pickard JD. Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol. 2013;9:152–63.PubMed Budohoski KP, Czosnyka M, Kirkpatrick PJ, Smielewski P, Steiner LA, Pickard JD. Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage. Nat Rev Neurol. 2013;9:152–63.PubMed
84.
go back to reference Adams HP. Early management of aneurysmal subarachnoid hemorrhage: a report of the cooperative aneurysm study. J Neurosurg. 1981;54:141–5.PubMed Adams HP. Early management of aneurysmal subarachnoid hemorrhage: a report of the cooperative aneurysm study. J Neurosurg. 1981;54:141–5.PubMed
85.
go back to reference Tomer JC, Nibbelink DW, Burmeister LF. Statistical comparisons of end results of a randomized treatment study. In: Sans AL, Nibbelink DW, Tomer JC, editors. Aneurysmal subarachnoid hemorrhage: report of the cooperative study. Baltimore, Md: Urban & Schwarzenberg; 1981. p. 249–276. Tomer JC, Nibbelink DW, Burmeister LF. Statistical comparisons of end results of a randomized treatment study. In: Sans AL, Nibbelink DW, Tomer JC, editors. Aneurysmal subarachnoid hemorrhage: report of the cooperative study. Baltimore, Md: Urban & Schwarzenberg; 1981. p. 249–276.
86.
go back to reference Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J. Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke. 1989;20(11):1511–5.PubMed Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J. Effect of fluid intake and antihypertensive treatment on cerebral ischemia after subarachnoid hemorrhage. Stroke. 1989;20(11):1511–5.PubMed
87.
go back to reference Bederson JB, Connolly Jr ES, Batjer HHM, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke. 2009;40(3):994–1025.PubMed Bederson JB, Connolly Jr ES, Batjer HHM, et al. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the stroke council, American Heart Association. Stroke. 2009;40(3):994–1025.PubMed
88.
go back to reference Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091–101.PubMed Ducros A, Boukobza M, Porcher R, et al. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain. 2007;130:3091–101.PubMed
89.
go back to reference Lu S, Liao Y, Fu JL, et al. Nimodipne for treatment of primary thunderclap headache. Neurology. 2004;62:1414–6.PubMed Lu S, Liao Y, Fu JL, et al. Nimodipne for treatment of primary thunderclap headache. Neurology. 2004;62:1414–6.PubMed
90.
go back to reference Chen SP, Fuh JL, Wang S. Reversible cerebral vaoconstriction syndrome: an under-recognised clinical emergency. Neurol Disord. 2010;3(3):161–71. Chen SP, Fuh JL, Wang S. Reversible cerebral vaoconstriction syndrome: an under-recognised clinical emergency. Neurol Disord. 2010;3(3):161–71.
91.
go back to reference Bouchard M, Verreault S, et al. Intra-arterial milrinone for reversible cerebral vasoconstrictor syndrome. Headache. 2009;49:142–5.PubMed Bouchard M, Verreault S, et al. Intra-arterial milrinone for reversible cerebral vasoconstrictor syndrome. Headache. 2009;49:142–5.PubMed
92.
go back to reference Lund-Johansen P. Pharmacology of combined alpha and beta blockade. Haemodynamic effects of labetalol. Drugs. 1984;28:35–50.PubMed Lund-Johansen P. Pharmacology of combined alpha and beta blockade. Haemodynamic effects of labetalol. Drugs. 1984;28:35–50.PubMed
93.
go back to reference Olsen K, Svendsen L, Lasen F, Paulson O. Effect of labetalol of cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth. 1995;75:51–4.PubMed Olsen K, Svendsen L, Lasen F, Paulson O. Effect of labetalol of cerebral blood flow, oxygen metabolism and autoregulation in healthy humans. Br J Anaesth. 1995;75:51–4.PubMed
94.
go back to reference Marek P, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131:1949–62. Marek P, Varon J. Hypertensive crises: challenges and management. Chest. 2007;131:1949–62.
95.
go back to reference Lui-DeRyke X, Janisse J, Coplin W, et al. A comparison of nicardipine and labetalol for acute hypertension management following acute stroke. Neurocrit Care. 2008;9:167–76. Lui-DeRyke X, Janisse J, Coplin W, et al. A comparison of nicardipine and labetalol for acute hypertension management following acute stroke. Neurocrit Care. 2008;9:167–76.
96.
go back to reference Lui-DeRyke X, Parker Jnr D, Levy P, et al. A prospective evaluation of labetalol versus nicardipine for acute hypertension management following stroke. Crit Care Med. 2009;37(suppl):161. Lui-DeRyke X, Parker Jnr D, Levy P, et al. A prospective evaluation of labetalol versus nicardipine for acute hypertension management following stroke. Crit Care Med. 2009;37(suppl):161.
98.
go back to reference Freiderich J, Butterworth J. Sodium nitroprusside: twenty years and counting. Anaesth Analg. 1995;81:152–62. Freiderich J, Butterworth J. Sodium nitroprusside: twenty years and counting. Anaesth Analg. 1995;81:152–62.
99.
go back to reference Rodrigues G, Varon J. A unique agent for the critical care practitioner: clevidipine. Crit Care Shock. 2006;9:37–41. Rodrigues G, Varon J. A unique agent for the critical care practitioner: clevidipine. Crit Care Shock. 2006;9:37–41.
100.
go back to reference Pollock C, Varon J, et al. Clevidipine is safe and effective for treatment of patients with acute severe hypertension. Ann Emerg Med. 2009;53:329–38. Pollock C, Varon J, et al. Clevidipine is safe and effective for treatment of patients with acute severe hypertension. Ann Emerg Med. 2009;53:329–38.
101.
go back to reference Aronson S, Dyke C, et al. The ECLIPSE trials: comparitive studies of clevidipine to nitroglycerine, sodium nitroprusside and nicardipine for treatment of acute hypertension in cardiac surgery patients. Anaesth Analg. 2008;107:1110–21. Aronson S, Dyke C, et al. The ECLIPSE trials: comparitive studies of clevidipine to nitroglycerine, sodium nitroprusside and nicardipine for treatment of acute hypertension in cardiac surgery patients. Anaesth Analg. 2008;107:1110–21.
102.•
go back to reference Graffagnino C, Bergese S, Love J, Schneider D, et al. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral haemorrhage: the ACCELERATE trial. Cerebrovasc Dis. 2013;36(173):180. This pilot study is the first to evaluate the safety and efficacy of clevidipine for rapid BP control in ICH. Clevidipine was effective and safe. Furthermore, patients showed minimal haematoma expansion which may warrant further investigation, particularly given ongoing uncertainty surrounding the effect of BP on hematoma growth in ICH. Graffagnino C, Bergese S, Love J, Schneider D, et al. Clevidipine rapidly and safely reduces blood pressure in acute intracerebral haemorrhage: the ACCELERATE trial. Cerebrovasc Dis. 2013;36(173):180. This pilot study is the first to evaluate the safety and efficacy of clevidipine for rapid BP control in ICH. Clevidipine was effective and safe. Furthermore, patients showed minimal haematoma expansion which may warrant further investigation, particularly given ongoing uncertainty surrounding the effect of BP on hematoma growth in ICH.
103.
go back to reference Bath PMW, Wilmot M, et al. Nitric oxide donors, L arginine or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev. 2002;4, CD001928. Bath PMW, Wilmot M, et al. Nitric oxide donors, L arginine or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev. 2002;4, CD001928.
104.
go back to reference Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies. A systematic review of the literature. J Gen Intern Med. 2002;17(12):937–45.PubMedPubMedCentral Cherney D, Straus S. Management of patients with hypertensive urgencies and emergencies. A systematic review of the literature. J Gen Intern Med. 2002;17(12):937–45.PubMedPubMedCentral
105.
go back to reference Hirschl MM, Binder M, Bur A, Herkner H, Müllner M, Woisetschläger C, et al. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. Intensive Care Med. 1997;23(8):885–8.PubMed Hirschl MM, Binder M, Bur A, Herkner H, Müllner M, Woisetschläger C, et al. Safety and efficacy of urapidil and sodium nitroprusside in the treatment of hypertensive emergencies. Intensive Care Med. 1997;23(8):885–8.PubMed
106.
go back to reference Buch J. Urapidil, a dual-acting antihypertensive agent: current usage considerations. Adv Ther. 2010;27(7):426–33.PubMed Buch J. Urapidil, a dual-acting antihypertensive agent: current usage considerations. Adv Ther. 2010;27(7):426–33.PubMed
Metadata
Title
Control of Blood Pressure in Hypertensive Neurological Emergencies
Authors
Lisa Manning
Thompson G. Robinson
Craig S. Anderson
Publication date
01-06-2014
Publisher
Springer US
Published in
Current Hypertension Reports / Issue 6/2014
Print ISSN: 1522-6417
Electronic ISSN: 1534-3111
DOI
https://doi.org/10.1007/s11906-014-0436-x

Other articles of this Issue 6/2014

Current Hypertension Reports 6/2014 Go to the issue

Blood Pressure Monitoring and Management (G Ogedegbe and JA Staessen, Section Editors)

Traditional Herbal Medicine Use Among Hypertensive Patients in Sub-Saharan Africa: A Systematic Review

Mediators, Mechanisms, and Pathways in Tissue Injury (T Fujita, Section Editor)

Angiotensin II and Vascular Injury

Hypertension and Metabolic Syndrome (JR Sowers and AT Whaley-Connell, Section Editors)

Fructose and Uric Acid: Is There a Role in Endothelial Function?

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine